10-97666533-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_018425.4(PI4K2A):c.1180G>A(p.Val394Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000706 in 1,613,718 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018425.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PI4K2A | NM_018425.4 | c.1180G>A | p.Val394Ile | missense_variant | 7/9 | ENST00000370631.4 | NP_060895.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PI4K2A | ENST00000370631.4 | c.1180G>A | p.Val394Ile | missense_variant | 7/9 | 1 | NM_018425.4 | ENSP00000359665 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000407 AC: 62AN: 152158Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000438 AC: 110AN: 251346Hom.: 0 AF XY: 0.000456 AC XY: 62AN XY: 135840
GnomAD4 exome AF: 0.000737 AC: 1077AN: 1461560Hom.: 1 Cov.: 30 AF XY: 0.000704 AC XY: 512AN XY: 727096
GnomAD4 genome AF: 0.000407 AC: 62AN: 152158Hom.: 0 Cov.: 32 AF XY: 0.000336 AC XY: 25AN XY: 74322
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 12, 2021 | The c.1180G>A (p.V394I) alteration is located in exon 7 (coding exon 7) of the PI4K2A gene. This alteration results from a G to A substitution at nucleotide position 1180, causing the valine (V) at amino acid position 394 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at